Navigation Links
PolyOne Announces Third Quarter 2011 Results
Date:10/25/2011

8.2–Impact on operating income

(4.9)(5.5)119.69.0Other income (expense), netGain on sale of investment in O'Sullivan

––0.50.4Royalty income

0.1–1.4–Loss on early extinguishment of debt

–(29.4)–(29.4)Impact on other income

0.1(29.4)1.9(29.0)Impact on income before income taxes

(4.8)(34.9)121.5(20.0)Income tax benefit (expense) on special items

1.713.1(45.7)7.5Impact of special items on net income

$  (3.1)$  (21.8)$   75.8$  (12.5)Basic impact per common share

$  (0.03)$  (0.23)$   0.81$  (0.13)Diluted impact per common share

$  (0.03)$  (0.23)$   0.80$  (0.13)Weighted average shares used to compute earnings per share:   Basic

91.893.193.092.8   Diluted

94.096.395.195.7(1) Special items is a non-GAAP financial measure. Special items include charges related to specific strategic initiatives or financial restructurings such as: consolidation of operations; debt extinguishment costs; employee separation costs resulting from personnel reduction programs, plant phaseout costs, executive separation agreements; asset impairments; mark-to-market adjustments associated with actuarial gains and losses on pension and other postretirement benefit plans; environmental remediation costs, fines or penalties for facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and equity investments; gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non-recurring items; and the effect of changes in tax law, accounting principles or other such laws or provisions affecting reported results or the effect of adverse determinations by regulatory
'/>"/>

SOURCE PolyOne Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. PolyOne GLS Selected as Healthcare Industry Marketing Specialist for Santoprene™ TPV Medical Grades
2. PolyOne Announces Sale of SunBelt Investment
3. PolyOne Features Non-Lead Radiation Protection at Medical Design and Manufacturing East Exhibition
4. PolyOnes Healthcare Solutions and Distribution Network Showcased at Medtec China
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , January 23, 2015 Heptares Therapeutics, ... delighted to announce that the Malcolm Campbell Memorial ... (Vice President of Chemistry), Fiona Marshall (Chief ... Executive Officer and co-founder) for the seminal contributions to GPCR ...
(Date:1/22/2015)... 22, 2015  BiOptix is pleased to announce the appointment ... of Chemistry and Biochemistry. Scott joins the company after previous ... Amgen throughout the course of his nearly 20 year ... is a nationally recognized thought leader in the biosensor ...
(Date:1/22/2015)... - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a ... cardiovascular disease and overall health is pleased to provide you ... its outlook for 2015 from the CEO, Mr. Eugene ... would like to take this opportunity to share with you ...
Breaking Medicine Technology:Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7
... Shire plc (LSE: SHP, Nasdaq: SHPGY ... a major medical meeting from a Phase IIIb study of ... (methylphenidate transdermal system) in adolescents aged 13 to 17 years ... In addition, data regarding the pharmacokinetic profile of Daytrana in ...
... Accuray Incorporated (Nasdaq: ARAY ), a global leader ... CyberKnife-focused abstracts have been accepted as part of the ... Oncology (ASTRO), taking place November 1 - 5 in ... CyberKnife abstracts over last year,s Annual Meeting. , The ...
Cached Medicine Technology:Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 2Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 3Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 4Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 5Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 6Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 7CyberKnife to be Focus of Numerous Presentations at the American Society for Radiation Oncology (ASTRO) Annual Meeting 2CyberKnife to be Focus of Numerous Presentations at the American Society for Radiation Oncology (ASTRO) Annual Meeting 3CyberKnife to be Focus of Numerous Presentations at the American Society for Radiation Oncology (ASTRO) Annual Meeting 4
(Date:1/22/2015)... Liberty University has received accreditation for its ... the Council for Accreditation of Counseling & Related Educational ... Center for Counseling & Family Studies , is under the ... new School of Behavioral Sciences. Prior to the formation of ...
(Date:1/22/2015)... Woodloch Pines, an all-inclusive family resort ... TripAdvisor as the number one best large hotel for families ... world for their annual Travelers’ Choice Awards. , TripAdvisor ... website is home to millions of unbiased and honest traveler ...
(Date:1/22/2015)... is a seasoned and trusted leader who consistently delivers trendy ... have it lead the wedding dress industry into the future. ... for the global market. , “The CEO of VogueQueen is ... on continuing the goal of operational excellence and giving back ...
(Date:1/22/2015)... EAGAN, Minn. (PRWEB) January 22, 2015 Blue ... discover those Minnesotans who exemplify what it means to “Live ... a chance for people to share their stories about how ... adversity or simply inspired others by living in the moment. ...
(Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and David ... Show to bestow a Juvent Sports Achievement award upon ... McKitrick. The award commemorated and congratulated McKitrick for her ... won her first amateur tournament in 1979 and most ...
Breaking Medicine News(10 mins):Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3
... SEGUNDO, Calif., Nov. 3 The Pancreatic ... national organization creating hope in a,comprehensive way ... for a cure, launches Raise Your Voice, ... Awareness Month. Raise Your Voice and make ...
... Nov. 3 Insulet Corporation,(Nasdaq: PODD ), ... the,International Diabetes Federation (IDF) today announced that Insulet ... (WDD) campaign. World Diabetes,Day, celebrated on November 14, ... spotlighting both the impact of the disease and,access ...
... BioCryst,Pharmaceuticals, Inc. (Nasdaq: BCRX ) today announced that ... will present,a corporate update at the Rodman and Renshaw ... 10, 2008 at 9:55 a.m. Eastern,Time. The conference will ... New York, New York., A link to a ...
... more common for adolescents illegally at the wheel, study finds, ... the thought of teenagers driving before they,ve gotten their license ... are also more likely to drive while drinking or on ... get behind the wheel. , Reporting in the November issue ...
... Therapeutics Inc. and to Continue,Trading on NASDAQ ... Cornerstone BioPharma,Holdings, Inc., a specialty pharmaceutical ... for respiratory disorders,today announced the completion of ... a biopharmaceutical company focused on,developing and commercializing ...
... Diabetes from Vision Loss, SAN FRANCISCO, Nov. 3 ... Currently, an estimated 17.9,million Americans have been diagnosed with diabetes. ... disease and 57 million people,are at risk of getting the ... is that all people with,diabetes -- both type 1 and ...
Cached Medicine News:Health News:Join the Pancreatic Cancer Action Network and Raise Your Voice in November for Pancreatic Cancer Awareness Month 2Health News:Join the Pancreatic Cancer Action Network and Raise Your Voice in November for Pancreatic Cancer Awareness Month 3Health News:Insulet Announces Sponsorship of International Diabetes Federation's World Diabetes Day Campaign 2Health News:Insulet Announces Sponsorship of International Diabetes Federation's World Diabetes Day Campaign 3Health News:BioCryst to Present at the Rodman and Renshaw 10th Annual Healthcare Conference 2Health News:BioCryst to Present at the Rodman and Renshaw 10th Annual Healthcare Conference 3Health News:Many Unlicensed Teen Drivers Put Safety Last 2Health News:Many Unlicensed Teen Drivers Put Safety Last 3Health News:Cornerstone BioPharma Announces Completion of Merger with Critical Therapeutics 2Health News:Cornerstone BioPharma Announces Completion of Merger with Critical Therapeutics 3Health News:Cornerstone BioPharma Announces Completion of Merger with Critical Therapeutics 4Health News:Cornerstone BioPharma Announces Completion of Merger with Critical Therapeutics 5Health News:EyeCare America Provides Free Dilated Eye Exams During Diabetes Awareness Month in November 2Health News:EyeCare America Provides Free Dilated Eye Exams During Diabetes Awareness Month in November 3
The HearTwave system is the original stand-alone Microvolt T-Wave Alternans (MTWA) testing platform....
... 3 mirror lenses featuring ultra-clear Volk 3-Mirror ... 76°, 66° and 60°. The 3 ... well central and peripheral fundus viewing and ... angled to eliminate gaps in the visualized ...
... Prism are designed for midperipherical ... for tractional retinal detachments (PDR, ... detachment. They can be used ... midperipheral laser applications. Direct image ...
... Prism is designed for ... are recommended for tractional ... etc.) and Rhegmatogenus retinal ... used for panretinal photocoagulation ...
Medicine Products: